FLCN and benign neoplasm: Pathogenic FLCN variants may lead to the inactivation of the gene, which destroys the ability of FLCN to restrict cell growth and division, resulting in deregulated cell growth and protein synthesis, giving rise to the formation of malignant and benign tumors (Balsamo et al., 2020).